International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
A novel human papillomavirus‑induced ‘doughnut wart’ lesion treated with 5‑aminolevulinic acid photodynamic therapy: A case report
The present study reports ‘doughnut wart’, a novel human papillomavirus (HPV)‑associated viral wart characterized by central regression and peripheral ring‑shaped proliferation after cryotherapy or other treatments, likely due to treatment‑altered microenvironments promoting viral spread. A 21‑year‑old female with a post‑cryotherapy plantar doughnut wart was treated with CO2 laser debridement followed by three weekly 5‑aminolevulinic acid photodynamic therapy (ALA‑PDT) sessions. Complete healing was achieved with no recurrence at 1 year. During the sixth follow‑up visit in June 2025, samples were collected from the patient for HPV detection, which confirmed the absence of recurrence. ALA‑PDT eliminates HPV‑infected cells through reactive oxygen species, activates local immunity (including immunogenic cell death) and preserves skin barriers, offering a precise, recurrence‑reducing approach superior to conventional therapies, which can disrupt barriers and promote viral spread.